ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026
Gut Microbiota-Derived Short-Chain Fatty Acids Driven by N-Carbamylglutamate Alleviates Premature Ovarian Failure Through Suppressing Ferroptosis.
Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Premature ovarian failure (POF) is characterized by abnormal ovulatory and ovarian endocrine functions in women before the age of 40, and is a leading cause of female infertility. Currently, effective drug treatments for this condition remain lacking in clinical practice. N-Carbamylglutamate (NCG) is a bioactive substance with anti-inflammatory and antioxidant properties; however, whether it can alleviate premature ovarian failure (POF) remains unclear. In this study, we utilized a cyclophosphamide (Cy)-induced POF model, combined with network pharmacology and in vivo validation, to investigate the potential effects and underlying mechanisms of NCG on POF. Our results revealed that ovarian aging progresses alongside activated ferroptosis. NCG treatment effectively reversed the pathological phenotypes of POF and inhibited ferroptosis in the ovary. These beneficial effects were mediated by activation of the NRF2/xCT/GPX4 axis. Furthermore, fecal microbiota transplantation (FMT) experiments validated that the gut microbiota serves as a key mediator of the POF-alleviating efficacy of NCG. 16S rDNA sequencing revealed that NCG modulated the gut microbiota composition in POF mice and increased the relative abundance of Lactobacillus. Additionally, targeted metabolomics analysis showed enrichment of short-chain fatty acids (SCFAs) in colonic contents and serum, with significantly elevated total SCFAs levels in ovarian tissues following NCG treatment. Mechanistically, the inhibition of ferroptosis mediated by gut microbiota-derived SCFAs represents a critical mechanism underlying the alleviation of POF. Specifically, the anti-ferroptotic activity of NCG depends on its capacity to promote SCFA biosynthesis, thereby activating the NRF2/xCT/GPX4 axis and ultimately exerting a POF-alleviating effect. These findings deepen our understanding of the gut-ovary axis in reproductive aging.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.